IVDR quant UR

Reproducible Metabolite Quantification in Urine

Urine metabolic analysis is particularly valuable and information-rich, because the metabolic pathways of a wide range of nutrients, drugs and environmental contaminants can be identified in urine, even if urine is very complex to analyze. Large sample cohorts in clinical studies demand automated solutions capable of measuring and analyzing with highest information content and reproducibility. 

The new B.I.QUANT-UR™ module of Bruker’s successful Avance® IVDr (In Vitro Diagnostics research) platform now provides precise, sensitive and fully reproducible results that have demonstrated great potential in preclinical animal and clinical/translational research.

Contact Us

B.I.QUANT-UR is available in three versions

  • ƒƒB.I.QUANT-UR b: basic version, 50 compounds with concentration ranges, occurring in most human urines
  • B.I.QUANT-UR e: extended version, 150 compounds with concentration ranges, age 6 month and up, also includingIEM and other disease markers
  • B.I.QUANT-UR ne: neonates extended version, 150 compounds with concentration range, also including disease markers and including non-targeted classification against healthy newborn model

Use B.I.QUANT-UR to further your studies in:

  • Epidemiology
  • Frequent diseases like kidney damage, diabetes, metabolic syndrome, obesity and cancer
  • Ability to monitor and optimize treatment
  • Microbiom related health problems
  • Food and environmental influence to health
  • Monitor compound concentrations in personalized urinary metabolic profile

The extended versions can be used in those applications plus:

  • Pediatrics 
  • Drug efficiency and treatment monitoring for IEM patients 
  • Functional food efficiency and dosage/composition 
  • Selective screening 
  • Neonatal health